Thyroid peroxidase antibodies: prevalence and assessment of immunological parameter in the context of search for new predictive markers of hypothyroidism

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND: The annual increase in the incidence of autoimmune pathologies, including autoimmune thyroiditis (AIT), emphasizes the relevance of studying the causes of their development and preventive measures. Despite the availability of analysis of antibodies to thyroid peroxidase (TPO), problems remain in accounting for statistical data on the prevalence of AIT. The importance of fundamental research in the search for prognostic markers of the progression of euthyroid carriage of antibodies to TPO to hypothyroidism lies in the need to determine the key molecular mechanisms for the development of more effective diagnostic and preventive strategies.

AIM: To assess the prevalence of TPO antibody carriage and to search for relationships between immunological parameters and the degree of thyroid dysfunction in AIT.

MATERIALS AND METHODS: The study involved 580 people over 18 years of age. The following data were analyzed: laboratory and instrumental data (blood test for thyroid-stimulating hormone, free thyroxine, antibodies to TPO); thyroid ultrasound data; anamnestic and immunological study data (regulatory T cells, regulatory B cells, B10 lymphocytes, interferon γ, interleukin (IL) IL-17, IL-4-producing T lymphocytes).

RESULTS: Positive titers of antibodies to TPO were detected in 143 individuals (24.7%), of which 73 patients (51.41%) had concomitant thyroid nodules and 60 patients (41.96%) had hypothyroidism. Statistically significant differences were obtained between carriers of antibodies to TPO and conditionally healthy individuals in the concentration of thyroid stimulating hormone, the presence of ultrasound signs of autoimmune changes and the presence of three or more children in the anamnesis (p <0.001). It was found that the concentration of antibodies to TPO statistically significantly correlated with the presence of many children (p=0.037). In the group of carriers of antibodies to TPO, a difference was found in the content of regulatory B cells during in vitro incubation with additional activation compared to healthy donors (p=0.039). However, reduced expression of IL-10 by these cells was not observed. No statistically significant differences in the content of regulatory T cells were found in the study groups; however, when a specific activator was added, a reduced degree of induction of these cells was observed, indicating their possible weakened functional activity, leading to disturbances in the control of autoaggression and suppression of autoreactive reactions.

CONCLUSION: The frequency of TPO antibody carriage is 24.6%. Women with many children have a significantly higher prevalence of AIT and statistically significantly higher titers of TPO antibodies in the blood, which allows us to consider having many children as a risk factor for the development of AIT. The study showed the expected difference in the number of regulatory B cells in TPO antibody carriers, but no reduced induction of IL-10 was observed. Further fundamental studies with larger target samples of individuals with AIT are needed in the search for new prognostic markers of the development and progression of the disease.

Full Text

Restricted Access

About the authors

Maria P. Kazakova

Endocrinology Research Centre

Email: kazakova.marya@endocrincentr.ru
ORCID iD: 0000-0002-9963-6783
SPIN-code: 6205-5170
Russian Federation, Moscow

Ekaterina A. Troshina

Endocrinology Research Centre

Email: troshina.ekaterina@endocrincentr.ru
ORCID iD: 0000-0002-8520-8702
SPIN-code: 8821-8990

MD, Dr. Sci. (Medicne), Professor, Corresponding Member of the Russian Academy of Sciences

Russian Federation, Moscow

Ilya N. Dyakov

I. Mechnikov Research Institute of Vaccines and Sera

Email: dyakov.ilya@gmail.com
ORCID iD: 0000-0001-5384-9866
SPIN-code: 1854-0958

Cand. Sci. (Biology)

Russian Federation, Moscow

Anastasiia P. Pershina-Miliutina

Endocrinology Research Centre

Email: oa11111998@gmail.com
ORCID iD: 0000-0002-9462-8522
SPIN-code: 6392-5111
Russian Federation, Moscow

Irina N. Chernyshova

I. Mechnikov Research Institute of Vaccines and Sera

Email: irina.n.chernyshova@gmail.com
ORCID iD: 0000-0001-5053-2433
SPIN-code: 7365-8382

MD, Cand. Sci. (Medicine)

Russian Federation, Moscow

Marina V. Gavrilova

I. Mechnikov Research Institute of Vaccines and Sera

Email: gavrilovamv@gmail.com
ORCID iD: 0000-0002-6936-2486
SPIN-code: 6348-7859

Cand. Sci. (Biology)

Russian Federation, Moscow

Christina K. Bushkova

I. Mechnikov Research Institute of Vaccines and Sera

Author for correspondence.
Email: christina_bushkova@mail.ru
ORCID iD: 0000-0002-4757-0751
SPIN-code: 8398-3378
Russian Federation, Moscow

References

  1. Miller FW. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Curr Opin Immunol. 2023;80:102266. doi: 10.1016/j.coi.2022.102266
  2. Conrad N, Misra S, Verbakel JY, et al. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet. 2023;401(10391):1878–1890. doi: 10.1016/S0140-6736(23)00457-9
  3. Clinical Recommendations ‘Hypothyroidism’ (approved by the Ministry of Health of Russia) [Internet]. (In Russ.) 2024. Available from: https://www.consultant.ru/document/cons_doc_LAW_486326/8efd5f17af55cb35a770f73937590c642437b7eb/
  4. Ajjan RA, Weetman AP. The pathogenesis of Hashimoto's thyroiditis: further developments in our understanding. Horm Metab Res. 2015;47(10):702–710. doi: 10.1055/s-0035-1548832
  5. Liu Y, Tang X, Tian J, et al. Th17/Treg cells imbalance and GITRL profile in patients with Hashimoto's thyroiditis. Int J Mol Sci. 2014;15(12):21674–21686. doi: 10.3390/ijms151221674
  6. Troshina EA, Makolina NP, Platonova NM, et al. The problem of iodine deficiency in the chechen republic: assessment of the current state and ways of solution. Problems of Endocrinology. 2023;69(4):38–49. EDN: UXOHBL doi: 10.14341/probl13306
  7. Hu X, Chen Y, Shen Y, et al. Global prevalence and epidemiological trends of Hashimoto’s thyroiditis in adults: A systematic review and meta-analysis. Front Public Health. 2022;10:1020709. doi: 10.3389/fpubh.2022.1020709
  8. Fadeev VV. Iodine deficiency and autoimmune thyroid diseases in the region of mild iodine deficiency: epidemiology, diagnostics, treatment [dissertation abstract]. Moscow; 2004. (In Russ.) EDN: ZMTZGH
  9. Rymar OD, Ragino YuI, Mustatina SV, Sherbakova LV. Prevalence of anti-thyroperoxidase antibodies in a population of Novosibirsk (25–69 years old): influences of age and sex. Bjulleten'' Sibirskogo otdelenija rossijskoj akademii medicinskih nauk. 2009;29(3):70–75. EDN: KYWHER
  10. Trunin EМ, Kerimov ES, Murt LL. Nodal transformation ofthyroid gland on the background of autoimmune thyroiditis. Vestnik of Saint Petersburg University. Medicine. 2008;(2):104–110. EDN: IUINDH
  11. Teng X, Shan Z, Chen Y, et al. More than adequate iodine intake may increase subclinical hypothyroidism and autoimmune thyroiditis: a cross-sectional study based on two Chinese communities with different iodine intake levels. Eur J Endocrinol. 2011;164(6):943–950. doi: 10.1530/EJE-10-1041
  12. Vanderpump M. Thyroid autoimmunity following an iodization programme*. Clin Endocrinol (Oxf). 2011;75(1):10–11. doi: 10.1111/j.1365-2265.2011.04044.x
  13. Fadeev VV, Mel’nichenko GA. Physiological doses of iodine and carriage of antibodies thyroid peroxidase: an open, randomized trial. Problems of Endocrinology. 2004;50(5):3–7. EDN: LSOSHZ doi: 10.14341/probl11509
  14. Pigarova EA, Mazurina NV, Troshina EA. Vitamin D in the prevention of bone and metabolic disorders. Consilium Medicum. 2019;21(4):84–90. EDN: UHOUSE doi: 10.26442/20751753.2019.4.190342
  15. Troshina EA, Senyushkina ES, Terekhova MA. The role of selenium in the pathogenesis of thyroid disease. Clinical and Experimental Thyroidology. 2018;14(4):192–205. EDN: NOEQGO doi: 10.14341/ket10157
  16. Marinkin IO, Sokolova TM, Makarov KYu, et al. Influence of hormonal contraception at women on the course of autoimmune thyroiditis. Medicina i obrazovanie v Sibiri. 2015;(3):56. EDN: VXOKKV
  17. Klyukina LA. Hormonal contraception in autoimmunity thyroiditis female patients of the reproductive age. V.F. Snegirev Archives of Obstetrics and Gynecology. 2017;4(2):73–76. EDN: XFQDBJ
  18. Khosrotehrani K, Johnson KL, Cha DH, et al. Transfer of fetal cells with multilineage potential to maternal tissue. JAMA. 2004;292(1):75–80. doi: 10.1001/jama.292.1.75
  19. Lepez T, Vandewoestyne M, Deforce D. Fetal microchimeric cells in autoimmune thyroid diseases: harmful, beneficial or innocent for the thyroid gland? Chimerism. 2013;4(4):111–118. doi: 10.4161/chim.25055
  20. Chen A, Huang L, Zhang L. Helper T cell 17 and regulatory t cell levels in peripheral blood of newly diagnosed patients with autoimmune thyroid disease: a meta-analysis. Horm Metab Res. 2023;55(1):40–50. doi: 10.1055/a-1972-5787
  21. Kang S, Kang J, Shen H, Wu N. Advances in regulatory B cells in autoimmune thyroid diseases. Int Immunopharmacol. 2021;96:107770. doi: 10.1016/j.intimp.2021.107770

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2024 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия  ПИ № ФС 77 - 86296 от 11.12.2023 г
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80632 от 15.03.2021 г
.